Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Mumbai

    Tag: Mumbai

    You Searched For "Mumbai"
    GSK Pharma sells 60 acres land in Thane to Oberoi Realty for Rs 890 crore

    GSK Pharma sells 60 acres land in Thane to Oberoi Realty for Rs 890 crore

    Medical Dialogues Bureau31 Aug 2019 12:54 PM IST
    Mumbai: Glaxo Smith Kline Pharmaceuticals (GSK) has divested around 60 acres of its lands at Thane in favour of Oberoi Realty for nearly Rs 890 crore...
    Lupin gets USFDA approval for generic version of Westcort cream to treat skin conditions

    Lupin gets USFDA approval for generic version of Westcort cream to treat skin conditions

    Farhat Nasim18 Aug 2019 9:46 AM IST
    Hydrocortisone Valerate cream is a generic version of Sun Pharmaceutical Industries Ltd's Westcort cream in the same strength, Lupin added.New Delhi:...
    Unichem Labs gets 4 USFDA observations for Goa formulation facility

    Unichem Labs gets 4 USFDA observations for Goa formulation facility

    Farhat Nasim3 Aug 2019 9:39 AM IST
    At the end of an inspection, the facility received four observations, with no repeat observations and are mostly procedural in nature, Unichem Labs...
    Cipla moves against NPPA for price fixation of asthma drugs; DOP junks plea

    Cipla moves against NPPA for price fixation of asthma drugs; DOP junks plea

    Farhat Nasim16 Jun 2019 11:44 AM IST
    New Delhi: Mumbai-based drugmaker, Cipla Limited's review petition against the Government regulatory agency, National Pharmaceutical Pricing Authority...
    Mediclaim cannot be denied on presumption of pre-existing disease: NCDRC

    Mediclaim cannot be denied on presumption of pre-existing disease: NCDRC

    Medical Dialogues Bureau9 Jun 2019 11:15 AM IST
    The commission also said in its view, diabetes was a lifestyle disease in India and the whole insurance claim (Mediclaim) cannot be rejected only...
    Indoco Remedies

    Indoco Remedies' new solid dosages facility at Baddi gets UK-MHRA nod

    Farhat Nasim11 May 2019 10:00 AM IST
    Indoco Remedies' new Baddi facility is spread over an area of 18000 sqm, with a manufacturing capacity of 4.3 billion tablets and 50 million capsules...
    Sole Bidder of SevenHills Hospital to restart operations, gets NCLT tribunal nod

    Sole Bidder of SevenHills Hospital to restart operations, gets NCLT tribunal nod

    Farhat Nasim24 April 2019 5:31 PM IST
    Mumbai: The fate of SevenHills Hospital has finally been pronounced as the National Company Law Tribunal (NCLT) has ruled in favour of BR Shetty, the...
    Cipla appoints Dr Raju Mistry as Global Chief People Officer

    Cipla appoints Dr Raju Mistry as Global Chief People Officer

    Medical Dialogues Bureau23 April 2019 9:15 AM IST
    In her role at Cipla, Raju Mistry will oversee Human Resources, and Administration and Facilities Management. She will be a member of the Management...
    Cipla acquires 30 percent stake in Brandmed for Rs 32 crore

    Cipla acquires 30 percent stake in Brandmed for Rs 32 crore

    Garima18 April 2019 9:15 AM IST
    The acquisition of Brandmed is expected to complete by May 31. The transaction worth Rs 32 crore will be executed by the company's South African arm...
    Lupin gets USFDA nod to Methylprednisolone tablets to treat inflammation

    Lupin gets USFDA nod to Methylprednisolone tablets to treat inflammation

    Farhat Nasim26 Feb 2019 9:50 AM IST
    The company has received approval from the US Food and Drug Administration (USFDA) to market Methylprednisolone tablets, a generic version of...
    SCHOTT KAISHA launches customizable prefillable glass syringes in India

    SCHOTT KAISHA launches customizable prefillable glass syringes in India

    Medical Dialogues Bureau1 Jan 2019 9:30 AM IST
    Rishad Dadachanji, Director, SCHOTT KAISHA shares, "The syriQ BioPure syringes, manufactured in St. Gallen, Switzerland, combine features to ensure...
    Lupin and AbbVie announces partnership to develop, commercialize Novel Oncology Drug

    Lupin and AbbVie announces partnership to develop, commercialize Novel Oncology Drug

    Medical Dialogues Bureau24 Dec 2018 9:30 AM IST
    Mumbai: Pharma major Lupin and global biopharmaceutical company AbbVie Inc., announced that AbbVie has licensed Lupin's MALT1 (Mucosa-Associated...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok